307 related articles for article (PubMed ID: 1419904)
1. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells.
Richon VM; Rifkind RA; Marks PA
Cell Growth Differ; 1992 Jul; 3(7):413-20. PubMed ID: 1419904
[TBL] [Abstract][Full Text] [Related]
2. Changes in p34cdc2 kinase activity and cyclin A during induced differentiation of murine erythroleukemia cells.
Kiyokawa H; Ngo L; Kurosaki T; Rifkind RA; Marks PA
Cell Growth Differ; 1992 Jun; 3(6):377-83. PubMed ID: 1419901
[TBL] [Abstract][Full Text] [Related]
3. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC.
Marks PA; Michaeli J; Jackson J; Richon VM; Rifkind RA
Prog Clin Biol Res; 1989; 316B():171-81. PubMed ID: 2616574
[TBL] [Abstract][Full Text] [Related]
4. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
Richon VM; Russo P; Venta-Perez G; Cordon-Cardo C; Rifkind RA; Marks PA
Cancer Res; 1997 Jul; 57(13):2789-98. PubMed ID: 9205091
[TBL] [Abstract][Full Text] [Related]
5. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
Chen ZX
Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):261-4. PubMed ID: 1806345
[TBL] [Abstract][Full Text] [Related]
6. Effect of sodium butyrate on the expression of retinoblastoma (RB1) and P53 gene and phosphorylation of retinoblastoma protein in human colon tumor cell line HT29.
Gope R; Gope ML
Cell Mol Biol (Noisy-le-grand); 1993 Sep; 39(6):589-97. PubMed ID: 8220069
[TBL] [Abstract][Full Text] [Related]
7. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
Marks PA; Ramsay R; Sheffery M; Rifkind RA
Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
[TBL] [Abstract][Full Text] [Related]
8. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
Marks PA; Rifkind RA
Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
[TBL] [Abstract][Full Text] [Related]
9. Modulation of gene expression during terminal cell differentiation: murine erythroleukemia.
Marks PA; Murate T; Kaneda T; Ravetch J; Rifkind RA
Symp Fundam Cancer Res; 1984; 37():327-40. PubMed ID: 6084863
[TBL] [Abstract][Full Text] [Related]
10. Conversion of differentiation inducer resistance to differentiation inducer sensitivity in erythroleukemia cells.
Michaeli J; Lebedev YB; Richon VM; Chen ZX; Marks PA; Rifkind RA
Mol Cell Biol; 1990 Jul; 10(7):3535-40. PubMed ID: 1972544
[TBL] [Abstract][Full Text] [Related]
11. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells.
Corin RE; Haspel HC; Peretz AM; Sonenberg M; Rifkind RA
Cancer Res; 1986 Mar; 46(3):1136-41. PubMed ID: 3455880
[TBL] [Abstract][Full Text] [Related]
12. Structural characterization of erythroid and megakaryocytic differentiation in Friend erythroleukemia cells.
Hyman T; Rothmann C; Heller A; Malik Z; Salzberg S
Exp Hematol; 2001 May; 29(5):563-71. PubMed ID: 11376868
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of retinoblastoma protein assayed in individual HL-60 cells during their proliferation and differentiation.
Juan G; Li X; Darzynkiewicz Z
Exp Cell Res; 1998 Oct; 244(1):83-92. PubMed ID: 9770352
[TBL] [Abstract][Full Text] [Related]
14. 12-O-tetradecanoylphorbol-13-acetate and staurosporine induce increased retinoblastoma tumor suppressor gene expression with megakaryocytic differentiation of leukemic cells.
Yen A; Varvayanis S; Platko JD
Cancer Res; 1993 Jul; 53(13):3085-91. PubMed ID: 8363661
[TBL] [Abstract][Full Text] [Related]
15. Synergistic action of activin A and hexamethylene bisacetamide in differentiation of murine erythroleukemia cells.
Yamashita T; Eto Y; Shibai H; Ogata E
Cancer Res; 1990 Jun; 50(11):3182-5. PubMed ID: 2334914
[TBL] [Abstract][Full Text] [Related]
16. Changes in E2F DNA-binding activity during induced erythroid differentiation.
Richon VM; Venta-Perez G
Cell Growth Differ; 1996 Jan; 7(1):31-42. PubMed ID: 8788031
[TBL] [Abstract][Full Text] [Related]
17. Co-induction of c-fos and junB during the latent period preceding commitment of Friend erythroleukemia cells to differentiation.
Francastel C; Mazouzi Z; Robert-Lézénès J
Leukemia; 1992 Sep; 6(9):935-9. PubMed ID: 1518304
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the c-myb, c-myc and p53 mRNA and protein levels during induced murine erythroleukemia cell differentiation.
Richon VM; Ramsay RG; Rifkind RA; Marks PA
Oncogene; 1989 Feb; 4(2):165-73. PubMed ID: 2648254
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
20. Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells.
Kiyokawa H; Richon VM; Rifkind RA; Marks PA
Mol Cell Biol; 1994 Nov; 14(11):7195-203. PubMed ID: 7935434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
